These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7719166)

  • 1. [Moyamoya disease in Taiwan].
    Su CF; Shih CJ; Lin LS; Hung TP
    J Formos Med Assoc; 1994 Sep; 93 Suppl 2():S90-7. PubMed ID: 7719166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological study of moyamoya disease in Taiwan.
    Hung CC; Tu YK; Su CF; Lin LS; Shih CJ
    Clin Neurol Neurosurg; 1997 Oct; 99 Suppl 2():S23-5. PubMed ID: 9409399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of moyamoya disease in Taiwan: a nationwide population-based study.
    Chen PC; Yang SH; Chien KL; Tsai IJ; Kuo MF
    Stroke; 2014 May; 45(5):1258-63. PubMed ID: 24676775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological and clinical features of Moyamoya disease in Nanjing, China.
    Miao W; Zhao PL; Zhang YS; Liu HY; Chang Y; Ma J; Huang QJ; Lou ZX
    Clin Neurol Neurosurg; 2010 Apr; 112(3):199-203. PubMed ID: 20004511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional differences in incidence and patient characteristics of moyamoya disease: a systematic review.
    Kleinloog R; Regli L; Rinkel GJ; Klijn CJ
    J Neurol Neurosurg Psychiatry; 2012 May; 83(5):531-6. PubMed ID: 22378916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ischemic stroke in childhood].
    Yoshida S; Yamamoto T; Yoshioka M; Kuroki S
    No Shinkei Geka; 1993 Jul; 21(7):611-6. PubMed ID: 8327052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moyamoya vasculopathy - Patient demographics and characteristics in the Finnish population.
    Saarela M; Mustanoja S; Pekkola J; Tyni T; Hernesniemi J; Kivipelto L; Tatlisumak T
    Int J Stroke; 2017 Jan; 12(1):90-95. PubMed ID: 27625049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moyamoya disease in Taiwan.
    Chen ST; Liu YH; Hsu CY; Hogan EL; Ryu SJ
    Stroke; 1988 Jan; 19(1):53-9. PubMed ID: 3336902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel epidemiological features of moyamoya disease.
    Baba T; Houkin K; Kuroda S
    J Neurol Neurosurg Psychiatry; 2008 Aug; 79(8):900-4. PubMed ID: 18077479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Moyamoya disease-analysis of 9 cases and review of the literature in Taiwan].
    Chou MS; Mei SN
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Feb; 7(2):62-8. PubMed ID: 2005673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of asymptomatic cerebral microbleeds in patients with hemorrhagic onset-type moyamoya disease: a phase-sensitive MRI study and meta-analysis.
    Qin Y; Ogawa T; Fujii S; Shinohara Y; Kitao S; Miyoshi F; Takasugi M; Watanabe T; Kaminou T
    Acta Radiol; 2015 Mar; 56(3):329-38. PubMed ID: 24558166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.
    Bao XY; Duan L; Li DS; Yang WZ; Sun WJ; Zhang ZS; Zong R; Han C
    Cerebrovasc Dis; 2012; 34(4):305-13. PubMed ID: 23146868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of the Hemorrhagic Site for Recurrent Bleeding: Prespecified Analysis in the Japan Adult Moyamoya Trial.
    Takahashi JC; Funaki T; Houkin K; Inoue T; Ogasawara K; Nakagawara J; Kuroda S; Yamada K; Miyamoto S;
    Stroke; 2016 Jan; 47(1):37-43. PubMed ID: 26645256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological survey of moyamoya disease in Korea.
    Ikezaki K; Han DH; Kawano T; Inamura T; Fukui M
    Clin Neurol Neurosurg; 1997 Oct; 99 Suppl 2():S6-10. PubMed ID: 9409396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and long-term outcome of postradiotherapy moyamoya syndrome in pediatric patients with primary brain tumors: a single institute experience in Taiwan.
    Wu YH; Chang FC; Liang ML; Chen HH; Wong TT; Yen SH; Chen YW
    Cancer Med; 2016 Aug; 5(8):2155-60. PubMed ID: 27265024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological and clinical features of moyamoya disease in the USA.
    Kainth D; Chaudhry SA; Kainth H; Suri FK; Qureshi AI
    Neuroepidemiology; 2013; 40(4):282-7. PubMed ID: 23445954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical comparison of definite moyamoya disease between South Korea and Japan.
    Ikezaki K; Han DH; Kawano T; Kinukawa N; Fukui M
    Stroke; 1997 Dec; 28(12):2513-7. PubMed ID: 9412642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
    Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
    J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed cerebral vasculopathy following cranial radiation therapy for pediatric tumors.
    Wang C; Roberts KB; Bindra RS; Chiang VL; Yu JB
    Pediatr Neurol; 2014 Jun; 50(6):549-56. PubMed ID: 24739378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey.
    Kuriyama S; Kusaka Y; Fujimura M; Wakai K; Tamakoshi A; Hashimoto S; Tsuji I; Inaba Y; Yoshimoto T
    Stroke; 2008 Jan; 39(1):42-7. PubMed ID: 18048855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.